Litigation

Recent Posts

2nd Circuit Upholds Fosamax Bellwether Defense Verdict
Posted on 31 Jan 2013 by Tom Moylan

NEW YORK - (Mealey's) A defense verdict for Merck, Sharp & Dohme in the fourth federal Fosamax jaw injury trial was upheld Jan. 30 by the Second Circuit U.S. Court of Appeals, which found that the trial court didn't err in excluding a plaintiff... Read More

Tags: Shark & Dohme Corp. , drugs , Linda Secrest v. Merck , Second Circuit , Food and Drug Administration , osteoporosism osteonecrosis of the jawm ONJ , Expert testimony , Linda Secrest , Merck , Litigation , Fosamax , In Re: Fosamax Products Liability Litigation

Fosamax MDL Jury: Drug Wasn't Defectively Designed, Didn't Cause Jaw Injury
Posted on 3 Oct 2011 by Tom Moylan

NEW YORK - A New York federal jury hearing the fourth Fosamax bellwether trial on Oct. 3 found that Merck's osteoporosis drug was not defectively designed and did not cause a plaintiff to develop osteonecrosis of the jaw (ONJ) ( In Re: Fosamax Products... Read More

Tags: osteonecrosis of the jaw , ONJ , Linda Secrest , Merck , drugs and devices , Litigation , osteoporosis drug , Linda Secrest v. Merck &amp , In Re: Fosamax Products Liability Litigation